Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Acceptability of the intervention: Study refusal rates |
The investigators will measure the feasibility of the intervention through acceptability quantitative analyses. These include the study refusal rates (i.e. the proportion of potentially eligible individuals for the study who chose not to participate). |
Baseline |
|
Primary |
Acceptability and demand of the intervention: Intervention retention rates |
The investigators will calculate the intervention retention rates (i.e. the proportion of individuals who were retained in the study) to measure the acceptability and demand of the intervention. |
12 months |
|
Primary |
Acceptability of the intervention: Focus groups and in-depth interviews |
The investigators will also measure the acceptability of the intervention through qualitative analyses including focus groups and in-depth interviews. Focus groups will be conducted with the participants between month 10 and month 12 of their participation in the intervention. These discussions will explore the perception and acceptance of each component of the intervention and potential future adaptations of the study. The in-depth interviews will be carried out to complement and extend the data collected in focus groups. Open-ended questions will be asked to assess 1) how the CBA intervention was perceived and accepted in each group; 2) any adaptations that would need to be made in future studies, and 3) the varying roles of the treatment supporter during the transition. |
10 months, 11 months, and 12 months |
|
Primary |
Demand of the intervention: Group attendance rates |
The investigators will assess demand to describe the extent to which the intervention is likely to be used. The investigators will calculate group attendance for study activities. Group attendance will be measured by the proportion of individuals who attended activities, the number of participants who attended at least one session, the median number of groups attended by participants who attended at least one session, the median number of participants per session, and the number of engagements (comments) during virtual sessions. |
12 months |
|
Primary |
Evidence of effectiveness of the intervention: combined antiretroviral therapy (cART) adherence |
The investigators will assess the evidence of effectiveness through cART adherence. (i.e. three questions to record self-adherence). The three questions will include, "How many days did you miss at least one dose of any of your ART medications?"; "How often did you take your ART medications correctly?" (5-point scale with 5 representing "always" and 1 representing "never"); and "How well would you say you took your HIV medications, as directed by your doctor?" (6-point scale with 6 representing "excellent" and 1 representing "very bad"). The investigators will calculate the within-person change from baseline to 6, 9, and 12 months to examine changes in outcome and determine if the intervention shows promise of success. |
Baseline, 6 months, 9 months, and 12 months |
|
Primary |
Evidence of effectiveness of the intervention: Psychosocial outcomes |
The investigators will assess the evidence of effectiveness through psychosocial outcomes including self-efficacy, quality of life, and perceived social and instrumental support. These outcomes will be measured using the NIH toolbox (version 2.0) for ages 18-85 on a 5-point ordinal scale ranging from "never" to "always", with higher scores indicating higher levels. The investigators will calculate the within-person change from baseline to 6, 9, and 12 months to examine changes in outcome and determine if the intervention shows promise of success. |
Baseline, 6 months, 9 months, and 12 months |
|
Primary |
Evidence of effectiveness of the intervention: Transition readiness through "Am I on Trac?" |
The investigators will assess transition readiness through "Am I On TRAC?" scales, which consist of knowledge and behavior indices adapted to the local context. The knowledge scale will assess the health condition and general medical self-care of the participant. The behavior scale will measure the frequency with which participants engage in individual health-related behaviors related to transition. The investigators will report the summed score of the subscales. The investigators will calculate the within-person change from baseline to 6, 9, and 12 months to examine changes in outcome and determine if the intervention shows promise of success. |
Baseline, 6 months, 9 months, and 12 months |
|
Primary |
Evidence of effectiveness of the intervention: Transition readiness through Got transition checklist |
The investigators will also assess transition readiness through the "Got Transition?" checklist (version 2.0). This checklist will analyze personal health knowledge and use of medical services. The questionnaire has a 3-point scale ranging from "not my responsibility" to "yes, I know this." The investigators will calculate the within-person change from baseline to 6, 9, and 12 months to examine changes in outcome and determine if the intervention shows promise of success. |
Baseline, 6 months, 9 months, and 12 months |
|